This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Afyx Development A/s. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: John Claude Krusz: Innovator in Cluster Headache Treatment
Introduction: John Claude Krusz is an inventor based in Dallas, TX (US). He is currently associated with Afyx Therapeutics A/S. Although he has not yet been granted any patents, his work focuses on innovative methods for treating cluster headaches.
Latest Patent Applications: John Claude Krusz has submitted a significant patent application titled "Intranasal Administration of Ketamine to Cluster Headache Patients." This application outlines a method for treating patients with cluster headaches through the intranasal administration of an aqueous composition containing a therapeutically effective amount of ketamine. The application emphasizes the potential to reduce or eliminate side effects associated with ketamine when used for this purpose. The composition is designed to be delivered in a nasal dosage form, such as a nasal spray.
Conclusion: John Claude Krusz is making strides in the field of headache treatment through his innovative approaches, particularly in the use of ketamine for cluster headache patients. His contributions may pave the way for new therapeutic options in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile